Kode Agalimmune
Pharmaceutical Manufacturing • • 1-10 Employees
Company overview
| Headquarters | XX |
| Website | |
| NAICS | 3254 |
| Employees | 1-10 |
Key Contact at Kode Agalimmune
John O'Toole
Executive Director
About Kode Agalimmune
Kode Agalimmune Ltd is a special purpose vehicle which has brought together human immuno-oncology assets of Kode Biotech Ltd, Kode Veterinary Sciences Ltd, BiolineRx Ltd and Agalimmune Ltd into a single entity positioned to develop nextgen oncology therapeutics.
$
Kode Agalimmune revenue & valuation
| Annual revenue | $256,665 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues | $821,328 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Director
Funding Data
Kode Agalimmune has never raised funding before.
United Arab Emirates
United States
Italy
France
United Kingdom
Frequently asked questions
Kode Agalimmune is located in XX.
Kode Agalimmune has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.
4.8
40,000 users
